Navigation Links
Accumed Research Associates Expands Capabilities In Phase I and Bioequivalence Clinical Trials
Date:5/7/2010

Leading Clinical Research Center Announces State-of-the-Art Overnight Facility

Garden City, NY (PRWEB) May 7, 2010 - Accumed Research Associates recently announced their continued growth by providing sleep study as well as overnight phase I and bioequivalence capabilities. Accumed, a leading clinical trials facility in Garden City, NY, now offers opportunities for all phases of clinical research with a well-equipped, state-of-the-art overnight facility for conducting clinical trials.

With more than nine years experience in all phases of clinical research studies, Dr. Mitchell Efros explained, “We wanted to become a complete research site and be able to deliver data in all aspects and phases of clinical trial research.” Dr Efros continued, “We expanded to include phase 1 and bioequivalence studies and are able to provide five associated physicians, two Nurse Practitioners as well as a Physician Assistant for our studies.”

Accumed has an extensive research database. Three research coordinators have more than16 years of combined research experience and support staff includes a data manager and regulatory specialist.

Many sponsors as well as contract research organizations (CRO’s) have utilized the expertise of Accumed and Dr. Efros for future direction and consultation. Accumed has over enrolled in more than 90% of recent trials conducted and has been the top enroller in a number of studies with enrollment performance status consistently at more than 95%.

Dr. Efros founded Accumed in 2001 and has successfully conducted more than 100 clinical trials. Accumed has become a well-known research center both in the local community and the industry due to its reputation for extensively trained employees who are dedicated to the highest standards of patient care. The site prepares for all monitoring visits and allots adequate time for the contract research associates (CRAs).

Dr. Efros and Accumed Research Associates are affiliated with the following prestigious research and medical organizations: Association of Clinical Research Professionals, Fellow of American College of Surgeons, American Urologic Association and American Association of Clinical Urologists.

Accumed Research Associates (http://www.AccumedResearch.com) is located in Garden City, NY on Long Island, and is a leader in clinical trials and studies. With more than nine years of experience in all phases of clinical research, Accumed Research Associates has access to a large research database and can prospectively identify suitable candidates for their clinical studies. The company’s strength includes its extensively trained employees dedicated to the highest standards of patient care as well as a state-of-the-art comprehensive facility, and research department.

# # #

Read the full story at http://www.prweb.com/releases/2010/05/prweb3945764.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Accumed Research Associates Launches Official Website
2. New research identifies modifiable risk factors for heart disease
3. Nuvo Research announces early redemption of 5% convertible debentures
4. Researcher to track spread of disease, malware and power outages
5. UCSF Researchers Identify Regulator of Human Sperm Cells
6. Octapharma Accepting Applications for Research Grants Through March 31
7. Valentine Tailgate Party for the Girls with Festive Ideas from Beauty Research
8. New Research Shows Genes of Pregnant Women and Their Fetuses Can Increase the Risk of Preterm Labor
9. University of Maryland chemist receives Astellas Award for blindness prevention research
10. Developing a cyberinfrastructure for comparative effectiveness in cancer research
11. Women should be allowed to eat, drink during labor: Queens University researcher
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains ... possible to save lost souls in the Philippines. “The Journey: From the Mountains to ... dedicated teacher of the Bible. She has taught all ages and currently teaches a ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017   Divoti USA ... up to the standard of the latest FDA requirements, which stipulates ... Anyone in need of Medical ID jewelry such as ... Jewelry are engraved in terms of the new FDA ... Divoti offers this ...
(Date:10/11/2017)... PARK, Calif. , Oct. 11, 2017  BioPharmX ... national scientific team that developed an innovative way to ... quantity of the delivery of new drugs. ... 2017 Fall Clinical Dermatology Conference will show how researchers ... General Hospital, Harvard Medical School used a suite of ...
(Date:10/11/2017)... 2017  True Health, a leader in integrated ... during National Breast Cancer Awareness month to educate ... Research recently published ... more than 10 million American women are at ... or BRCA2 and have not had testing. These mutations ...
Breaking Medicine Technology: